Titan Pharmaceuticals INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Titan Pharmaceuticals reports its financial results for the year ended December 31, 2024, highlighting a net loss and ongoing efforts to complete a merger with TalenTec Sdn. Bhd.
Titan Pharmaceuticals reports a net loss of $5.6 million for 2023, transitioning to a product development company after selling its ProNeura assets.